Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Hi-Clearance's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.09.
Hi-Clearance's long-term debt to total assets ratio
declined
from Dec. 2024 (0.11) to Dec. 2025 (0.09).
It may suggest that Hi-Clearance is progressively becoming less dependent on debt to grow their business.
LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.
Hi-Clearance LT-Debt-to-Total-Asset Related Terms
Hi-Clearance LT-Debt-to-Total-Asset Historical Data
* Premium members only.
The historical data trend for Hi-Clearance's LT-Debt-to-Total-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hi-Clearance (ROCO:1788) has a LT-Debt-to-Total-Asset of 0.09 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Hi-Clearance and its competitors.
Is Hi-Clearance's LT-Debt-to-Total-Asset too high?
Hi-Clearance's current LT-Debt-to-Total-Asset is 0.09. Overall, Hi-Clearance has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hi-Clearance's LT-Debt-to-Total-Asset compare to ABT and SYK?
Hi-Clearance's LT-Debt-to-Total-Asset of 0.09 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Hi-Clearance and its competitors. Hi-Clearance's current LT-Debt-to-Total-Asset is 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hi-Clearance stock overvalued right now?
Based on GuruFocus' analysis, Hi-Clearance (ROCO:1788) is currently considered Fairly Valued. The stock's GF Value™ is NT$138.61, compared to a current price of NT$130.00 — trading 6.2% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.09. Hi-Clearance's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Hi-Clearance (ROCO:1788), the current LT-Debt-to-Total-Asset is 0.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hi-Clearance (ROCO:1788) Overvalued in 2026?
Based on GuruFocus' analysis, Hi-Clearance stock appears to be undervalued.
The current stock price of NT$130.00 is trading 6.2% below its estimated GF Value™ of NT$138.61.
GuruFocus considers Hi-Clearance to be Fairly Valued.
Key valuation signals for ROCO:1788:
LT-Debt-to-Total-Asset: 0.09
GF Value™: NT$138.61 vs. price of NT$130.00 (6.2% below fair value)
No single metric tells the full story. See the ROCO:1788 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hi-Clearance Inc primary business activities involve trading medical equipment, biochemical reagents, and Western medicine. It has two segments Hemodialysis Division responsible for the procurement and distribution of a wide range of blood dialysis-related consumables, which are sold to hospitals, clinics, and distributors; and Other business segments mainly involved in selling dental materials and other products. The company generates majority of revenue from Hemodialysis Division. Its products are Single Patient Dialysis System TORAY, TORAYLIGHT Hollow Fiber Dialyzer, FILTRYZER TORAY, TORAY ETRF.
79GF Score
Get the complete analysis for ROCO:1788
LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1788 has been successfully added to your 
